Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphoma

Leuk Lymphoma. 2025 May 7:1-4. doi: 10.1080/10428194.2025.2496333. Online ahead of print.
No abstract available